NASDAQ Composite ended the session with Gilead Sciences rising 3.67% to $65.80 on Monday, after four consecutive sessions in a row of losses. NASDAQ Composite slid 0.48% to $13,895.12, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Gilead Sciences today’s close was $65.80, 30.38% below its 52-week high of $85.79.
The company’s growth estimates for the ongoing quarter is 57.7% and a drop 20.4% for the next.
Gilead Sciences’s Revenue
Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 25.56B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Gilead Sciences’s stock is considered to be overbought (>=80).
Gilead Sciences’s Stock Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $65.80 at 17:38 EST, way under its 52-week high of $85.79 and way above its 52-week low of $56.56.
Gilead Sciences’s Moving Average
Gilead Sciences’s worth is higher than its 50-day moving average of $64.10 and above its 200-day moving average of $62.44.
More news about Gilead Sciences.